Ypsomed Holding AG (SWX: YPSN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
364.00
-16.00 (-4.21%)
Nov 15, 2024, 5:31 PM CET

Ypsomed Holding AG Company Description

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.

The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.

This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.

This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services.

It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors.

It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG
Ypsomed Holding AG logo
Country Switzerland
Founded 1984
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 2,296
CEO Simon Michel

Contact Details

Address:
Brunnmattstrasse 6
Burgdorf, 3401
Switzerland
Phone 41 34 424 41 11
Website ypsomed.com

Stock Details

Ticker Symbol YPSN
Exchange SIX Swiss Exchange
Fiscal Year April - March
Reporting Currency CHF
ISIN Number CH0019396990
SIC Code 3842

Key Executives

Name Position
Simon Michel Chief Executive Officer and Member of the Board
Samuel Kunzli Chief Financial Officer
Frank Mengis Chief Operating Officer
Thomas Kutt Head of Investor Relations
Dr. Nicolas Meyer Chief Legal Officer and Secretary
Michael Zaugg Chief Corporate Officer
Ulrike Bauer Chief Business Officer of Ypsomed Delivery Systems
Sebastien Delarive Chief Business Officer of Ypsomed Diabetes Care